Gelsectan®

DEVICE2 trials

Sponsors

Istituto Clinico Humanitas, Devintec Sagl

Conditions

Irritable Bowel Syndrome (IBS)Irritable Bowel Syndrome of Diarrhea Type (IBS-D)Low Anterior Resection Syndrome

Unknown Phase

Effect of Gelsectan® in the Treatment of Low Anterior Resection Syndrome

RecruitingNCT06162143

Istituto Clinico HumanitasLow Anterior Resection Syndrome

Start: 2023-11-15End: 2025-11-15Target: 73Updated: 2024-01-10

Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome

RecruitingNCT06681012

Devintec SaglIrritable Bowel Syndrome (IBS), Irritable Bowel Syndrome of Diarrhea Type (IBS-D)

Start: 2024-10-22End: 2027-07-01Target: 330Updated: 2026-04-03